Video: Neural Stem Cells and CNS Disorder
Posted on November 25th, 2009 | by Stem Cell News |What is a neural stem cell? How can they help treat neurological disorders such as Alzheimer’s disease, Parkinson’s disease, spinal cord injury, stroke, ALS (Lou Gehrig’s Disease)? Evan Snyder of the Burnham Institute helps define neural stem cells (NSC), explaining that they are relatively inaccessible in the adult patient, but that they seem to benefit from some immunotolerance.
It follows that we may be able to use readily available lines of embryonic stem cells for therapy in neurodegenerative disease. Evan reviews current clinical applications for neural stem cells (including as a vehicle for small molecule delivery), and gives his future outlook for neural stem cells. Evan forsees NSCs being used in anti-inflammatory and neuroprotective functions, to deliver tumor killing genes, and to build iPS drug discovery models.
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_c.png?x-id=2c94c2a6-09aa-4920-bc57-b686147d9b51)
Related posts:
- Video: StemCells Inc. using Neural Stem Cells for their Neuroprotective Effect
Discover StemCells, Inc. A pioneer in the field of neural stem cells, StemCells Inc was founded by the renown Irving Weissman, Fred Gage, and David Anderson. Martin McGlynn, CEO, presents - Stem cells bring new insights to future treatment of vision and neural disorders
Deep in the brain, buried in the hippocampus and subventricular zone, reside adult neural stem cells, cells that retain the ability to become other types of neural cells and could - Travel to far East to get a therapy
A growing trend in USA takes some desperate Americans, unhappy with the US law, travel far away up to China and Thailand, for treatments they hope will help them.Click here to view the embedded video.
Click here to view the embedded video.
from
- Stem Cell Research Grows Up
Click here to view the embedded video.
from ABC news
- CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent
CD133 (Prominin) is widely used as a marker for the identification and isolation of neural precursor cells from normal brain or tumor tissue. However, the assumption that CD133 is expressed